DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2901 | Kb-r7785 | Novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the in |
|
| DCC2902 | Kc-11404 | LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor,and 5-lipoxygenase |
|
| DCC2903 | Kca075 | Highly specific transglutaminase 2 (TG2) inhibitor |
|
| DCC2904 | Kca-1490 | Dual PDE3/4 inhibitor |
|
| DCC2905 | Kca2 Positive Modulator 2q | Novel potent and Subtype-Selective Positive Modulator of KCa2 Channels |
|
| DCC2906 | Kcal01 | Potent PDZ domain peptide inhibitor that rescues CFTR activity |
|
| DCC2907 | Kdm4c-in-35 | Novel selective KDM4C inhibitor |
|
| DCC2908 | Kdm4-in-i | Novel KDM4 inhibitor |
|
| DCC2909 | Kdoam-20 | Potent and selective KDM5 inhibitor |
|
| DCC2910 | Kdoam-21 | Potent and selective KDM5 inhibitor |
|
| DCC2911 | Kemptide Acetate Salt | Phosphate acceptor peptide substrate for cAMP-dependent protein kinase |
|
| DCC2912 | Kf15372 | Potent and selective adenosine A1 antagonist with renal protective and diuretic activities |
|
| DCC2913 | Kfa1982 | Novel and potent factor Xa inhibitor |
|
| DCC2914 | Kgchm07 | Novel potent peptide dual agonist of opioid/neurokinin 1 receptor |
|
| DCC2915 | Kh-carb13 Hydrochloride | Novel Pim-1 kinase Inhibitor, dose-dependent decreasing the viability of LS174T and HCT-116 cells |
|
| DCC2916 | Khg21834 | Inhibitor of Aβ-induced inflammation |
|
| DCC2917 | Khg26693 | Novel anti-inflammatory and antioxidant agent, significantly decreasing blood glucose, triglycerides, and cholesterol and increased insulin |
|
| DCC2918 | Ki23057 | Novel FGFR2 inhibitor, enhancing the chemosensitivity of drug-resistant gastric cancer cell lines |
|
| DCC2919 | Kif18a Inhibitor 23 | Novel KIF18A inhibitor, causing significant mitotic arrest in vivo, binding at the interface of KIF18A and tubulin |
|
| DCC2920 | Ki-ms2-008 | Novel Max-binding modulator, attenuating Myc-driven transcription and stabilizing the Max homodimer |
|
| DCC2921 | kin100 | Novel inducer of the ISG54 promoter, causing IRF-3 translocation |
|
| DCC2922 | Kir1.1-in-a | Novel potent and selective inhibitor of kir1.1 channels |
|
| DCC2923 | Kist301072 | Novel ROS1 kinase inhibitor |
|
| DCC2924 | Kist301080 | Novel ROS1 kinase inhibitor |
|
| DCC2925 | Kjm429 | Novel TRPV1 antagonist |
|
| DCC2926 | Kj-pyr-10 | Novel specific inhibitor of MYC |
|
| DCC2927 | Kkha-761 | Potent D3 receptor antagonist with high 5-HT1A receptor affinity |
|
| DCC2928 | Kl-1156 | Novel NF-κB inhibitor and lipopolysaccharide (LPS)-induced nitric oxide production inhibitor |
|
| DCC2929 | Kld-12 | Self-assembling peptide, forming a hydrogel matrix to support growth of cells in the presence of an ionic solution, enhancing chondrogenic differentiation of bone marrow stromal cells (BMSCs) |
|
| DCC2930 | Klebsazolicin | Novel inhibitor of 70S ribosome by obstructing the peptide exit tunnel |
|
